Elizabeth (Beth) Rendina-Ruedy, Ph.D.

Elizabeth (Beth)
Rendina-Ruedy
Ph.D.
Assistant Professor
Medicine, Division of Clinical Pharmacology
Assistant Professor
Molecular Physiology and Biophysics
Member
Molecular Pathology and Immunology

Background

Dr. Rendina-Ruedy’s unique training and research experience is deeply rooted in the basic science of bone biology with an emphasis in nutritional biochemistry. She received her Ph.D. from the College of Human Sciences with an emphasis in Nutritional Sciences in May 2014 from Oklahoma State University under the mentorship of Dr. Brenda Smith. While her M.S. focused on bioactive foods and bone health, her Ph.D. research was aimed at investigating the role of autophagy in bone metabolism as it related to type 2 diabetes mellitus skeletal fragility. She then transitioned to a postdoctoral fellowship in the Department of Orthopaedic Surgery and Rehabilitation at VUMC, in the Vanderbilt Center for Bone Biology (VCBB) in Dr. Daniel Perrien’s lab.  During this time her project focused on how the histone deacetylase, sirtuin1 (Sirt1), was involved in mechanotransduction of bone. She then continued her postdoctoral training under Dr. Clifford Rosen’s mentorship at the Maine Medical Center Research Institute (MMCRI).  While at MMCRI Dr. Rendina-Ruedy’s research interest returned to cellular bioenergetics and metabolic pathways within the skeletal niche.

Dr. Rendina-Ruedy’s current work focusses on developing a comprehensive understanding of how metabolic pathways impact bone health.  Within this scope, the Rendina-Ruedy lab’s vision is to identify novel biological mechanisms to develop new treatments that can improve the quality of life for patients with compromised bone health.

Complete Bibliography

Phone
(615) 875-5247
Office Address
Medical Research Building IV/ Light Hall
2215B Garland Ave
Room / Suite
1155C
Nashville
Tennessee
37232-0575

The Rendina-Ruedy Lab is focused on developing a comprehensive understanding of how metabolic pathways impact bone health. Bone is an incredibly dynamic tissue that undergoes continuous remodeling involving bone resorbing osteoclasts, bone forming osteoblasts, and mechano-sensing osteocytes. Due to the high energetic demands of this process targeting metabolic pathways in bone cells is an incredibly provocative tool that can be applied to combat various conditions which lead to increased fracture incidence (i.e., post-menopausal osteoporosis, type 2 diabetes mellitus, and age-related osteoporosis). As such, the Rendina-Ruedy lab has ongoing projects aimed at understanding how bone cells, and cells within the bone marrow niche, store, mobilize, and utilize various metabolic substrates.  In addition to understanding how these metabolic pathways impact bone health in a cell-autonomous manner, our lab is particularly interested in how alterations in bone cell bioenergetics modulates whole-body metabolism.

elizabeth.rendina-ruedy@vumc.org

Staff Scientist, Maine Medical Center Research Institute, 2017-2019

Postdoctoral Fellow, Maine Medical Center Research Institute, 2015-2017

Postdoctoral Fellow, Orthopaedic Surgery and Rehabilitation, 2014-2015, Vanderbilt University Medical Center

Ph.D. Nutritional Sciences, 2014, Oklahoma State University

M.S. Nutritional Sciences, 2009, Oklahoma State University

B.S. Biochemistry, 2007, Oklahoma State University

Simmons Publications

  1. Simmons J, Zeitler P, Fenton L, Abzug M, Fiallo-Scharer R, Klingensmith G. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type I diabetes mellitus:  a case report and review of the literature. Pediatric Diabetes. 6:4, December 2005, 234-238. PMID: 16390393
  2. Simmons J, McFann K, Brown A, Rewers A, Follansbee D, Temple-Trujillo R, Klingensmith G.  Reliability of the Diabetes Fear of Injecting and Self-Testing Questionnaire (D-FISQ) in Pediatric Patients with Type 1 Diabetes.  Diabetes Care.

Dahir Publications

  1. Ectopic ACTH Hypersecretion Due to a Primary Pulmonary Paraganglioma, Kathryn McCrystal Dahir, Adriana L. Gonzalez, Monica P. Revelo, Rafeeq Ahmed,  John R. Roberts, and Lewis S. Blevins, Jr.  Endocrine Practice. 2004 Sep-Oct; 10(5):424-8
  2. Treatment of Adult Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: A Clinical Practice Audit, Howard Y. Li, M.D., Kathryn McCrystal Dahir, M.D. and Lewis S. Blevins, Jr., M.D.  Endocrine Practice.

Archer's Publications

  1. Ficke JR, Obremsky WT, Gaines RJ, Pasquina PF, Bosse MJ, Mamczak CN, O’Toole RV, Archer KR, Born CT, Fleming ME, Watson JT, Gordon WT, Stannard JP, Rispoli DM, MacKenzie EJ, Wenke JC, Hsu JR, Pollak AN, and Anderson R.  Extremity War Injuries VII – A Decade of War: Reprioritization of Research for Combat Casualty Care. J Am Acad Orthop Surg. (In press)
  2. Archer KR, Castillo RC, Wegener ST, Abraham CM, and Obremskey W. Pain and Satisfaction in Hospitalized Trauma Patients: The importance of Self-efficacy and Psychological Distress.

Park Publications

  1. Zhang H, Yu C, Dai J, Keller JM, Hua A, Sottnik JL, Shelley G, Hall CL, Park SI, Yao Z, Zhang J, McCauley LK, Keller ER.  Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of beta-catenin activation of the DKK1 promoter in prostate cancer.  Oncogene.  2013; (in press)
  2. Jin R., Sterling JA, Edwards JR, Degraff DJ, Lee C, Park SI, Matusik RJ.  PLoS One.  2013; 8(4):e60983.
  3. Ding X, Park SI, McCauley LK, Wang CY.  Signaling Between Transforming Growth Factor ß (TGF-ß) and Transcription Factor SN
RSS: